You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast Cancer
|
---|---|
Published in |
Journal of Clinical Oncology, March 2008
|
DOI | 10.1200/jco.2007.12.0733 |
Pubmed ID | |
Authors |
Chau Dang, Monica Fornier, Steven Sugarman, Tiffany Troso-Sandoval, Diana Lake, Gabriella D'Andrea, Andrew Seidman, Nancy Sklarin, Maura Dickler, Violante Currie, Theresa Gilewski, Mary Ellen Moynahan, Pamela Drullinsky, Mark Robson, Carolyn Wasserheit-Leiblich, Nancy Mills, Richard Steingart, Katherine Panageas, Larry Norton, Clifford Hudis |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
Spain | 2 | 3% |
India | 1 | 1% |
South Africa | 1 | 1% |
United States | 1 | 1% |
Unknown | 71 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 19% |
Student > Ph. D. Student | 9 | 12% |
Student > Master | 9 | 12% |
Other | 8 | 10% |
Student > Bachelor | 6 | 8% |
Other | 20 | 26% |
Unknown | 11 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 54% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Nursing and Health Professions | 3 | 4% |
Agricultural and Biological Sciences | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 4 | 5% |
Unknown | 19 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2020.
All research outputs
#4,722,688
of 22,896,955 outputs
Outputs from Journal of Clinical Oncology
#9,190
of 19,980 outputs
Outputs of similar age
#15,746
of 80,192 outputs
Outputs of similar age from Journal of Clinical Oncology
#58
of 131 outputs
Altmetric has tracked 22,896,955 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,980 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 80,192 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.